Levetiracetam Tablet, Film Coated
Product Images NDC 50090-6086

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-6086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-of-levet1 (Figure Of Levet1)

Figure-of-levet1 (Figure Of Levet1)
FDA Label Image

Figure-of-levet2 (Figure Of Levet2)

Figure-of-levet2 (Figure Of Levet2)
This text shows the number of patients in each group for a study comparing the effects of a placebo, levetiracetam at 1000 mg/day, and levetiracetam at 2000 mg/day. It does not offer any information about the study outcomes or the conditions being treated.*
FDA Label Image

Figure-of-levet3 (Figure Of Levet3)

Figure-of-levet3 (Figure Of Levet3)
This text provides information about the number of patients in two different groups, one receiving a placebo treatment (104 patients) and the other group receiving a treatment of levetiracetam at 3000 mg/day (180 patients). The information is presented as a percentage of patients, but the actual percentages are not provided.*
FDA Label Image

Figure-of-levet4 (Figure Of Levet4)

Figure-of-levet4 (Figure Of Levet4)
The text shows the percentage of patients who were treated with a placebo (N=97) and levetiracetam (N=101). The percentage of patients who had positive outcomes from levetiracetam treatment is not specified.*
FDA Label Image

Figure-of-levet5 (Figure Of Levet5)

Figure-of-levet5 (Figure Of Levet5)
This text provides statistical information about the effectiveness of a medication called Levetiracetam compared to a placebo. It indicates that out of 51 patients who were given a placebo, only 19.6% showed improvement. On the other hand, out of 58 patients who were given Levetiracetam, 43.1% showed improvement.*
FDA Label Image

Figure-of-levet6 (Figure Of Levet6)

Figure-of-levet6 (Figure Of Levet6)
This text represents a summary of a clinical study that evaluated the efficacy of a drug named Levetiracetam compared to a Placebo. The effectiveness of both drugs was evaluated based on the percentage of patients who experienced positive results. The study included 84 patients in the Placebo group and 79 patients in the Levetiracetam group.*
FDA Label Image

Label Image (Lbl500906086)

Label Image (Lbl500906086)
This appears to be a product package for a medication called "Teleriraceran". The product number is 6722-0 and there are 30 tablets included in the package. The dosage and intended use are not indicated in the provided text.*
FDA Label Image

Levestructure (Levestructure)

Levestructure (Levestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.